Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective Dose
PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment
20
Participants
Timeline
Start Date
December 15, 2014
Primary Completion Date
October 8, 2020
Study Completion Date
December 8, 2021
Conditions
Telangiectasia, Hereditary Hemorrhagic
Interventions
DRUG
bevacuzimab spray
Trial Locations (1)
14033
CHU de Caen, Caen
All Listed Sponsors
lead
University Hospital, Caen
OTHER
NCT02157987 - Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective Dose | Biotech Hunter | Biotech Hunter